TXN and Miyoshi myopathy: TXN inactivation using the CRISPR-Cas9 strategy in MM cell lines (Fig. 3C,D; Supplemental Figs. S12B,C, S13) led to a significant reduction of growth rate as compared to control cells (Fig. 3E; Supplemental Fig. S12D).